GeNeuro (FRA:GEM) Buyback Yield %: 0.00 (As of Jul. 12, 2026)


FRA:GEM GeNeuro SA FRA:GEM
8 GF Score
Price €0.03
View Full Analysis

What is GeNeuro Buyback Yield %?

GeNeuro FRA:GEM 8 Buyback Yield % is 0.00 as of Jul. 12, 2026. GuruFocus rates FRA:GEM with a GF Score™ of 8/100.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

GeNeuro's current buyback yield was 0.00%.

GeNeuro Buyback Yield % Historical Data

* Premium members only.

The historical data trend for GeNeuro's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GeNeuro Buyback Yield % Chart

GeNeuro Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -17.90 -7.96 -19.96 0.00

GeNeuro Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.64 -13.14 -20.56 0.00 0.00

FRA:GEM vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, GeNeuro's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeNeuro Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeNeuro's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where GeNeuro's Buyback Yield % falls into.


FRA:GEM
8GF Score
GeNeuro SA FRA:GEM
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GeNeuro Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

GeNeuro's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 23.492964
=0.00%

GeNeuro's annualized Buyback Yield for the quarter that ended in Dec. 2023 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 23.492964
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
GeNeuro (FRA:GEM) has a Buyback Yield % of 0.00 as of Jul. 12, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on GeNeuro and its competitors.
Is GeNeuro's Buyback Yield % too high?
GeNeuro's current Buyback Yield % is 0.00. Overall, GeNeuro has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does GeNeuro's Buyback Yield % compare to VRTX and REGN?
GeNeuro's Buyback Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on GeNeuro and its competitors. GeNeuro's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GeNeuro stock overvalued right now?
GeNeuro (FRA:GEM) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. GeNeuro's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For GeNeuro (FRA:GEM), the current Buyback Yield % is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GeNeuro Business Description

Address 3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).
8GF Score

Get the complete analysis for FRA:GEM

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price